IRIS UniCatt

Deodato, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.438
EU - Europa 6.769
AS - Asia 6.328
SA - Sud America 1.085
AF - Africa 212
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 10
Totale 22.857
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.182
SG - Singapore 3.049
DE - Germania 2.510
CN - Cina 1.400
SE - Svezia 1.230
BR - Brasile 898
IT - Italia 653
FR - Francia 577
VN - Vietnam 565
UA - Ucraina 518
IN - India 313
GB - Regno Unito 312
IE - Irlanda 279
FI - Finlandia 219
ID - Indonesia 197
JP - Giappone 169
CA - Canada 150
HK - Hong Kong 120
RU - Federazione Russa 118
TR - Turchia 107
BD - Bangladesh 85
AR - Argentina 69
IQ - Iraq 58
NL - Olanda 58
MX - Messico 55
CI - Costa d'Avorio 50
BE - Belgio 49
ZA - Sudafrica 49
PL - Polonia 42
ES - Italia 34
IR - Iran 34
CZ - Repubblica Ceca 32
SA - Arabia Saudita 30
AT - Austria 29
EC - Ecuador 29
MA - Marocco 26
EG - Egitto 24
UZ - Uzbekistan 24
PH - Filippine 20
PK - Pakistan 20
CL - Cile 19
CO - Colombia 18
VE - Venezuela 17
KE - Kenya 16
LT - Lituania 16
CH - Svizzera 15
JM - Giamaica 15
TN - Tunisia 15
KR - Corea 14
NP - Nepal 14
RO - Romania 13
AU - Australia 12
JO - Giordania 12
PY - Paraguay 12
AE - Emirati Arabi Uniti 11
BG - Bulgaria 11
UY - Uruguay 10
MY - Malesia 9
AZ - Azerbaigian 7
DZ - Algeria 7
IL - Israele 7
PE - Perù 7
RS - Serbia 7
SN - Senegal 7
AL - Albania 6
AM - Armenia 6
BO - Bolivia 6
DK - Danimarca 6
KG - Kirghizistan 6
KZ - Kazakistan 6
LK - Sri Lanka 6
CR - Costa Rica 5
EU - Europa 5
GR - Grecia 5
HN - Honduras 5
LU - Lussemburgo 5
NI - Nicaragua 5
OM - Oman 5
PS - Palestinian Territory 5
PT - Portogallo 5
SY - Repubblica araba siriana 5
TT - Trinidad e Tobago 5
TW - Taiwan 5
DO - Repubblica Dominicana 4
ET - Etiopia 4
AO - Angola 3
BH - Bahrain 3
HR - Croazia 3
HU - Ungheria 3
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
MD - Moldavia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AG - Antigua e Barbuda 2
BS - Bahamas 2
EE - Estonia 2
KW - Kuwait 2
MK - Macedonia 2
Totale 22.823
Salva come PNG Salva come JPEG
Città #
Singapore 1.653
Chandler 1.233
San Jose 842
Ashburn 785
Beijing 333
Jacksonville 287
Dublin 276
San Mateo 258
The Dalles 210
Los Angeles 209
New York 199
Lauterbourg 187
Ho Chi Minh City 186
Nanjing 180
Jakarta 172
Wilmington 172
Dearborn 160
Hanoi 150
Boston 139
Tokyo 138
Bremen 125
Milan 123
Nürnberg 114
Frankfurt am Main 107
Munich 105
Woodbridge 104
Hong Kong 102
Marseille 98
São Paulo 97
Ann Arbor 96
Hefei 85
Lawrence 82
Rome 80
Cattolica 79
Helsinki 79
Princeton 77
Dallas 74
Hyderabad 73
Izmir 69
Houston 68
Moscow 68
Nanchang 65
Fairfield 60
Redwood City 56
Toronto 56
Seattle 54
Abidjan 50
Chicago 50
Brussels 49
Buffalo 48
Orem 48
Santa Clara 48
Guangzhou 36
Leawood 33
St Louis 33
University Park 33
Zhengzhou 33
Augusta 32
Boardman 31
Fremont 31
Kunming 31
Shanghai 31
Shenyang 31
Düsseldorf 30
Paris 30
London 29
Phoenixville 29
Brooklyn 28
Norwalk 28
Redmond 28
Stockholm 28
Amsterdam 27
Atlanta 27
Montreal 27
Hebei 26
Tianjin 26
Turku 26
Warsaw 26
Da Nang 24
Lancaster 24
Mountain View 24
Council Bluffs 23
Jiaxing 23
Lappeenranta 22
Pune 22
Rio de Janeiro 22
Changsha 21
Detroit 21
North York 21
Johannesburg 20
Memphis 20
Mexico City 20
Mumbai 20
Nuremberg 20
Tashkent 20
Auburn Hills 19
Falls Church 19
Kent 19
Hangzhou 18
Phoenix 18
Totale 11.488
Salva come PNG Salva come JPEG
Nome #
Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastases 297
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? 227
Short-Course Accelerated Radiotherapy in Palliative Treatment of Advanced Pelvic Malignancies: A Phase I Study 226
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 220
Radioprotective effect of moderate wine consumption in patients with breast carcinoma. 219
Volumetric modulated arc therapy with simultaneous integrated boost for locally advanced rectal cancer 212
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 195
A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. 192
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 192
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma 191
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity 190
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. 189
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 188
Planning comparison between standard and conformal 3D techniques in post-operative radiotherapy of gastric cancer: a systematic review 188
Long-term Analysis of Gemcitabine-based Chemoradiation after Surgical Resection for Pancreatic Adenocarcinoma 187
Endocavitary in vivo dosimetry for IMRT treatments of gynecologic tumors 186
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 185
Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer 185
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 183
Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study 180
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 176
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 175
In Vivo Portal Dosimetry by an Ionization Chamber 174
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 174
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 174
A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases 174
Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1) 174
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 171
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 171
Early radiation-induced mucosal changes evaluated by proctoscopy: Predictive role of dosimetric parameters 170
Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial 169
Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study 169
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 165
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 164
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 164
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 164
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase ii study (ester-1). 162
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 162
Incidence and management of noncancer pain in cancer patients referred to a radiotherapy center 159
Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: a Phase I study 158
Eccrine Syringofibroadenoma radiation treatment of an unusual presentation 157
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial 157
Short-course radiotherapy in elderly patients with early stage non-melanoma skin cancer: a phase II study 157
Forward-planned intensity modulated radiation therapy using a cobalt source: A dosimetric study in breast cancer 156
Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer 155
Initial clinical experience with Epid-based in-vivo dosimetry for VMAT treatments of head-and-neck tumors 155
A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 154
FOLFIRI-bevacizumab and concurrent low-dose radiotherapy in metastatic colorectal cancer: preliminary results of a phase I-II study 153
A phase I dose-escalation study (iside-bt-1) of accelerated imrt with temozolomide in patients with glioblastoma. 151
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 151
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 151
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 150
Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases 150
Interventional radiotherapy as exclusive treatment for primary nasal vestibule cancer: Single-institution experience 150
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 149
Real time transit dosimetry for the breath-hold radiotherapy technique experience 147
Low-dose radiotherapy and concurrent FOLFIRI-bevacizumab: A Phase II study 145
INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures 145
CT angiography-based radiomics as a tool for carotid plaque characterization: a pilot study 143
Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1). 141
Feasibility Study Of Moderately Accelerated Intensity-Modulated Radiotherapy Plus Concurrent Weekly Cisplatin After Induction Chemotherapy In Locally Advanced Head-And Neck Cancer. 141
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 140
Neoadjuvant Accelerated Concomitant Boost Radiotherapy and Multidrug Chemotherapy in Locally Advanced Rectal Cancer: A Dose-Escalation Study 140
Stereotactic radiotherapy in recurrent gynecological cancer: a case series 139
Concurrent Chemoradiation with Concomitant Boost in Locally Advanced Rectal Cancer: A Phase II Study 139
Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Patients With Brain Oligometastases: A Phase 1 Study (ISIDE-BM-1) 139
Cervical cancer patterns of care in Italy: A radiation oncology survey of MITO and AIRO GYN groups 139
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 138
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: Preliminary results of a phase II trial 138
Correction to: Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patients (Journal of Cancer Research and Clinical Oncology, (2021), 147, 3, (661-667), 10.1007/s00432-020-03411-7) 138
Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients 137
Palliative short-course radiation therapy in rectal cancer: A phase 2 study 137
INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures 137
Dabrafenib-Trametinib and Radiotherapy for Oligoprogressive BRAF Mutant Advanced Melanoma 136
Phase I-II studies on accelerated IMRT in breast carcinoma: Technical comparison and acute toxicity in 332 patients. 136
Palliative two-dimensional radiotherapy of pancreatic carcinoma: a feasibility study. 136
Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial 136
Pain REduction with bone metastases STereotactic radiotherapy (PREST): A phase III randomized multicentric trial 136
18 F-FDG Pet-Guided External Beam Radiotherapy in Iodine-Refractory Differentiated Thyroid Cancer: A Pilot Study 135
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase II study (ESTER-1). 132
Volumetric modulated arc therapy (VMAT) and simultaneous integrated boost in head-and-neck cancer: Is there a place for critical swallowing structures dose sparing? 132
Linac-based extracranial radiosurgery with Elekta volumetric modulated arc therapy and an anatomy-based treatment planning system: Feasibility and initial experience 132
Radiotherapy of prostate carcinoma: A comparison of the predictive role of EAU versus NCCN risk stratification systems 130
Efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic/persistent/recurrent ovarian cancer: a prospective, multicenter phase II study (MITO-RT3/RAD) 128
Personalized Automation of Treatment Planning for Linac-Based Stereotactic Body Radiotherapy of Spine Cancer 128
Efficacy of stereotactic body radiotherapy and response prediction using artificial intelligence in oligometastatic gynaecologic cancer 127
Palliative radiotherapy indications during the COVID-19 pandemic and in future complex logistic settings: the NORMALITY model 127
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 126
Predictive Factors of Late-onset Rectal Mucosal Changes After Radiotherapy of Prostate Cancer 126
Optimal beam margins in linac-based VMAT stereotactic ablative body radiotherapy: A Pareto front analysis for liver metastases 126
Synchronous male carcinoma of the breast, exocrine pancreas, and prostate 124
Daily on-line set-up correction in 3D-conformal radiotherapy: is it feasible? 124
Short course accelerated radiation therapy (SHARON) in palliative treatment of advanced solid cancer in older patients: A pooled analysis 124
A Large, Multicenter, Retrospective Study on Efficacy and Safety of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 123
Clinical Studies on Ultrafractionated Chemoradiation: A Systematic Review 123
An atlas for clinical target volume definition, including elective nodal irradiation in definitive radiotherapy of biliary cancer 122
Progestin-releasing intrauterine device insertion plus palliative radiotherapy in frail, elderly uterine cancer patients unfit for radical treatment 121
Advanced head and neck cancer in older adults: Results of a short course accelerated radiotherapy trial 121
Prognostic Score in Radiotherapy Practice for Palliative Treatments (PROPHET) Study for Bone Metastases: An Investigation Into the Clinical Effect on Treatment Prescription 120
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 119
Totale 15.670
Salva come PNG Salva come JPEG
Categoria #
all - tutte 93.046
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.046
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202135 0 0 0 0 0 0 0 0 0 0 0 35
2021/20221.513 139 87 21 107 119 51 25 224 58 116 283 283
2022/20233.480 472 477 243 584 207 404 189 277 394 41 144 48
2023/20241.424 66 422 57 110 38 158 92 118 13 44 193 113
2024/20253.078 73 80 208 112 348 76 58 154 527 357 593 492
2025/20268.302 1.229 228 404 757 1.492 485 1.394 508 662 660 342 141
Totale 23.152